Mobile Application for Self-Management of Type 2 Diabetes Mellitus
NCT ID: NCT06176703
Last Updated: 2023-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
128 participants
INTERVENTIONAL
2023-11-22
2025-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The effect of mobile application on glycemic control and quality of life of diabetes mellitus patients
* The satisfaction of mobile application of diabetes mellitus patients who used it Participants will be received education about diabetes mellitus and separated into two groups, intervention group(using mobile application) and control group(not using mobile application but also receive standard treatment of diabetes mellitus.
Researchers will compare intervention group to control group about glycemic control including HbA1c, complications of diabetes mellitus etc. and quality of life.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard treatment with mobile application in diabetes mellitus patients
mobile application
using mobile application along with standard treatment of diabetes mellitus
standard treatment without mobile application in diabetes mellitus patients
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mobile application
using mobile application along with standard treatment of diabetes mellitus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can use application on smartphone
* age 18 years old or more (relatives are accept if participants have age more than 65 years old and cannot use smartphone)
* consent to participate the research
Exclusion Criteria
* pregnancy
* using continuous glucose monitoring system or insulin pump
* disability in sight or hearing
* have been using the mobile application(RAMAdiabetes) in the past
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ramathibodi Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Supasuta Wongdama
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chutintorn Sriphrapradang
Role: STUDY_DIRECTOR
Ramathibodi Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Ramathibodi Hospital
ฺBangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Supasuta Wongdama
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5370
Identifier Type: -
Identifier Source: org_study_id